Oculomotor Assessment of Traumatic Brain Injury (TBI)

NCT03156010 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2023-08-23

No results posted yet for this study

Summary

The purpose of the proposed study is to compare the sensitivity and specificity of three oculomotor test devices in normal subjects versus subjects with history of TBI. The study is designed as a prospective research project in which a group of 120 normal controls without a history of TBI will be compared to another group of 120 participants (total of 240) who have a confirmed history of TBI. Each participant will complete the TBI assessment protocol for each of three separate devices (Neuro Kinetics, SyncThink, and Oculogica). The order of the devices will be counter-balanced across participants. Participants will also be screened for vestibular migraine and visual vertigo, which are two conditions that influence oculo-vestibular perception in normal and TBI patients and might influence the results from the three oculomotor devices. Data from each device will be utilized to perform AUC analyses to determine the respective sensitivity and specificity for each.

Conditions

Interventions

DEVICE

Neuro Kinetics IPAS

Testing with PAS device

DEVICE

Oculogica EyeBox

Testing with Oculogica EyeBox device

DEVICE

SyncThink EyeSync Device

Testing with SyncThink EyeSync device

Sponsors & Collaborators

  • Neurolign

    collaborator INDUSTRY
  • Sync-Think, Inc.

    collaborator INDUSTRY
  • Oculogica, Inc.

    collaborator INDUSTRY
  • TBICoE

    collaborator UNKNOWN
  • United States Department of Defense

    collaborator FED
  • Walter Reed National Military Medical Center

    lead FED

Principal Investigators

  • Louis French, PsyD · NICoE

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-18
Primary Completion
2023-04-19
Completion
2023-04-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03156010 on ClinicalTrials.gov